ArticleOncology letters2024

Hexokinase 2 as an independent risk factor for worse patient survival in esophageal adenocarcinoma and as a potential therapeutic target protein: A retrospective, single‑center cohort study.

Su Ir Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.